首页> 外文期刊>Clinical and Translational Gastroenterology >Human |[beta]|-Defensin 2 in Primary Sclerosing Cholangitis
【24h】

Human |[beta]|-Defensin 2 in Primary Sclerosing Cholangitis

机译:原发性硬化性胆管炎中的人|β|-防御素2

获取原文
       

摘要

Objectives:Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease of the bile ducts frequently associated with inflammatory bowel disease (IBD), suggesting an important role for the gut–liver axis. Defensins are small (3.5–4.5?kDa) anti-microbial peptides that contribute to innate immunity at mucosal surfaces and have been implicated in IBD. The aim of this study was to investigate copy number variation of the gene (DEFB4) encoding human β-defensin 2 (HBD2) and protein expression of HBD2 in PSC.
机译:目的:原发性硬化性胆管炎(PSC)是一种常与炎症性肠病(IBD)相关的慢性胆管炎性疾病,提示其对肠肝轴的重要作用。防御素是小的(3.5–4.5?kDa)抗菌肽,有助于粘膜表面的先天免疫,并与IBD有关。这项研究的目的是研究编码人β-防御素2(HBD2)的基因(DEFB4)的拷贝数变异和PSC中HBD2的蛋白表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号